Richard Wilson completed his medical degree at the Queen’s University Belfast (QUB) and then worked in N. Ireland and Scotland as a junior doctor during which he engaged in three years of basic science research in colorectal cancer for which he received his doctoral degree. He subsequently trained in clinical oncology in N. Ireland and attained UK accreditation. Following this, he undertook a Fellowship at the National Cancer Institute in the US National Institutes of Health in Bethesda, Maryland, where he received specialist training in medical oncology, early phase cancer clinical trials and drug development. He returned to the UK as a Senior Lecturer in the Centre for Cancer Research and Cell Biology in QUB and Honorary Consultant Oncologist in the Belfast Health and Social Care Trust. He set up the first early phase cancer clinical trials programme on the island of Ireland, and also the N. Ireland Cancer Trials Network. He was Clinical Director of this regional network and Clinical Lead of the Belfast Experimental Cancer Medicine Centre until the end of 2018. He works as a medical oncologist in lower gastrointestinal cancer (mainly in colorectal cancer but also in small bowel cancer and peritoneal malignancies) and conducts biological, translational and clinical research in these diseases. He is Chief Investigator on many local, national and international cancer clinical trials in both early and late phase settings. He previously chaired the UK National Cancer Research Institute Colorectal Cancer Clinical Studies Group and is a member of its Adjuvant and Advanced Disease Subgroup. He moved on 01 February 2019 from his position as Professor in Cancer Medicine in QUB to the Institute of Cancer Sciences in the University of Glasgow where he is now Professor of Gastrointestinal Oncology. Richard is also an Honorary Consultant in Medical Oncology in the Beatson West of Scotland Cancer Centre.